Clinical Capabilities
Prenatal diagnostic tests carry up to a 1.5% risk of miscarriage. Non-invasive preclinical testing (NIPT) can provide parents with a risk rating before diagnostic tests are performed. PRENITA™ NIPT detects a range of aneuploidies and microdeletions from as early as 10 weeks. Speak to your health care provider to arrange your PRENITA™ NIPT.
BOOK A TEST → DOWNLOAD BROCHURE → VIEW FAQS →
Diagnostic prenatal tests, such as chorionic villus sampling and amniocentesis, are highly accurate but carry a 0.5 – 1.5 % risk of miscarriage. While maternal screening serum tests negate this risk, they typically carry a 5% chance of false-positive results.
PRENITA™ NIPT combines the merits of both techniques by negating the risk of miscarriage and reducing the chance of false-positive results.
With greater sensitivity and specificity of PRENITA™ NIPT, it is expected that the number of women undergoing unnecessary invasive testing will be reduced.
PRENITA™ NIPT is the most advanced, non-invasive prenatal screening test. With just 10 ml of maternal blood, we can analyse every chromosome to check for genetic conditions that could affect your baby’s health.
Following analysis, PRENITA™ NIPT provides a genetic score for the conditions tested:
There are several benefits of choosing PRENITA™ NIPT over other prenatal screening techniques, including:
✓ Early detection at 10 weeks
✓ Reduced risk of false positives
✓ Increased sensitivity and specificity
✓ Short turnaround time of 10 days
✓ Information on every chromosome
REPROCELL) also offer follow-up services to PRENITA™ NIPT, including personalized genetic counselling and confirmatory tests for high risk pregnancies.
PRENITA™ NIPT can be offered to any expectant mother who wants information on the genetic condition of her baby, and is recommended to expectant mothers with:
✓ Advanced maternal age
✓ Positive maternal serum screen
✓ Abnormal ultrasound findings
✓ Positive personal or family history
If you are unsure whether PRENITA™ NIPT is right for you, or if you require further information, speak to your healthcare provider or download our FAQs document.
BROCHURE
Download our brochure and learn more about PRENITA™ NIPT.
WEBSITE
Find out more about PRENITA™ NIPT on the official website.
FAQs
View our FAQs document to find out more about PRENITA™ NIPT.
Human Tissue Samples
Precision Medicine Services
Preclinical Genomic Services
Discover how testing your inflammatory skin compounds in fresh diseased tissue from human patients can help avoid clinical failure.
REPROCELL
Products
Services
© 2021 REPROCELL Inc. All rights reserved.
REPROCELL Inc. 日本語 MetLife Shin-yokohama 381, Bldg. 9F, 3-8-11 Shin-yokohama, Kohoku-ku, Yokohama, Kanagawa 222-0033, Japan
REPROCELL USA Inc. 9000 Virginia Manor Road, Suite 207, Beltsville, 20705, USA
REPROCELL Europe Ltd. Thomson Pavilion, Todd Campus, West of Scotland Science Park, Acre Road, Glasgow, G20 0XA, United Kingdom
Bioserve Biotechnologies (India) PVT Ltd. Unit: D4-D7, 1st Floor, Industrial Estate, Moula Ali, Medchal-Malkajgiri Dist., Hyderabad-500040, Telangana, India